ABC | Volume 112, Nº3, Março 2019

Artigo de Revisão Jorge et al Imagem na disfunção ventricular por quimioterapia Arq Bras Cardiol. 2019; 112(3):309-316 Este é um artigo de acesso aberto distribuído sob os termos da licença de atribuição pelo Creative Commons 33. Fallah-Rad N, Walker JR, Wassef A, Lytwyn M, Bohonis S, Fang T, et al. The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor ii–positive breast cancer treated with adjuvant trastuzumab therapy. J Am Coll Cardiol. 2011;57:2263-70. 34. Aiken MJ, Suhag V, Garcia CA, Acio E, Moreau S, Priebat DA, et al . Doxorubicin-induced cardiac toxicity and cardiac rest gated blood poll imaging. Clin Nucl Med. 2009;34(11):762-7. 35. Schwartz RG, JainD, Storozynsky E. Traditional and novel methods to assess andpreventchemotherapy-relatedcardiacdysfunctionnoninvasively. JNucl Cardiol. 2013;20(3):443-64. 36. Corbett JR, Akinboboye OO, Bacharach SL, Borer JS, Botvinick EH, DePuey EG, et al. Equilibrium radionuclide angiocardiography. J Nucl Cardiol.2006;13(6):e56-e79. 37. Strashun AM, Goldsmith SJ, Horowitz SF. Gated blood pool scintigraphic monitoring of doxorubicin cardiomyopathy: comparison of camera and computerized probe results in 101 patients. J Am Coll Cardiol.1986;8(5):1082-7. 38. Armenian SH, Lacchetti C, Barac A, Carver J, Constine LS, Denduluri N, et al. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical PracticeGuideline. J Clin Oncol. 2016;35:893-911. 39. Fatima N, Zaman UM, Hashmi A, Kamal S, Hameed A. Assessing adriamycin-induced early cardiotoxicity by estimating left ventricular ejection fraction using technetium-99m multiple-gated acquisition scan and echocardiography. Nucl Med Commum.2011;32(5):381-5. 40. Tantawy AA, Elmasry AO, ShaabanM, ToaimaDN, Shahat AM. Radionuclide ventriculography detects early anthracycline cardiotoxity in children with Hodgkin Lymphoma. J Pediatr Hematol Oncol.2011;33:e132-e137. 41. Pepe A, Pizzino F, Gargiulo P, Perrone-Filardi P, Cadeddu C, Mele D, et al. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascularmagneticresonanceandnuclearcardiology JCardiovascMed 2016, 17 (suppl 1):e45–e54 42. Debatin JF, Nadel SN, Paolini JF, Sostman HD, Coleman RE, Evans AJ, et al . Cardiac ejection fraction: phantom study comparing cine MR imaging, radionuclide blood pool imaging, and ventriculography. J Magn Reson Imaging.1992;2(2):135-42. 43. Moon JC, Lorenz CH, Francis JMm, Smith JC, Pennell DJ. Breath-hold FLASH and FISP cardiovascularMR imaging: left ventricular volume differences and reproducibility. Radiology.2002;223(3):789-97. 44. Drafts BC, Twomley KM, D’Agostino R Jr, Lawrence J, Avis N, Ellis LR, et al . Low tomoderate dose anthracycline-based chemoterapy is associatedwith early noinvasive imaging evidence of subclinical cardiovascular disease. JACC Cardiovasc Imag. 2013;6(8):877-85. 45. Armstrong GT, Plana JC, Zhang N, Srivastava D, Green DM, Ness KK, et al . Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiacmagnetic ressonance imaging. J Clin Oncol. 2012;30:2876-84. 46. Hundley WG. MRI in detecting heart damage in patients with cancer receiving chemotherapy. http://clinicaltrials.gov/show/NCT01719562. Accessed june 27, 2017. 47. Bollache E, Redheuil A, Clément-Guinaudeau S, Defrance C, Perdrix L, Ladouceur M et al . Automated left ventricular diastolic function evaluation from phase-contrast cardiovascular magnetic resonance and comparison withDoppler echocardiography. J CardiovascMagn Reson. 2010;12(1):63. 48. Paelinck BP, de Roos A, Bax JJ, Bosmans JM, van Der Geest RJ, Dhondt D, et al. Feasibility of tissue magnetic resonance imaging a pilot study in comparison with tissue Doppler imaging and invasive measurement. J Am Coll Cardiol.2005;45(7);1109-16. 49. Friedman MA, Bozdech MJ, Billingham ME, Rider AK. Doxorubicin cardiotoxicity: Serial endomyocardilal biopsies and systolic time intervals. J AmMed Assoc. 1978;240(15):1603-6. 50. Unverferth DV, Fetters JK, Unverferth BJ, Leier CV, Magorien RD, Arn Ar, et al . Human myocardial histologic characteristics in congestive heart failure. Circulation.1983;68(6):1194-200. 51. Souto ALM, Souto RM, Teixeira ICR, Nacif MS. Myocardial viability on cardiac magnetic ressonance. Arq Bras Cardiol.2017;108(5):458-69. 52. Nathan M, Liu CY, Pierre C, David B, Lima JAC. Assessment of myocardial fibrosis with cardiac magnetic resonance. J Am Coll Cardiol.2011;57(8):891-903. 53. SibleyCT , NoureldinRA, GaiN , NacifMS, LiuS, TurkbeyEB, etal .T1Mapping in cardiomyopathy at cardiacMR: comparisonwith endomyocardial biopsy. Radiology.2012;265(3):724-32. 54. Jordan JH, Vasu S, Morgan TM, D’Agostino Jr RB, Meléndez GC, Hamilton CA, et al. Anthracycline-Associated T1mapping characteristics are elevated independent of the presence of cardiovascular comorbidities in cancer survivors. Circ Cardiovasc Imaging.2016;9:e004325. 55. Lota AS, Gatehouse PD, Mohiaddin RH. T2 mapping and T2* imaging in heart failure. Heart Fail Rev.2017;22:431-40. 56. Thavendiranathan P, Amir E, Bedard P, Crean A, Paul N, Nguyen ET, et al. Regional myocardial edema detected by T2 mapping is a feature of cardiotoxicity in breast cancer patients receiving sequential therapy with anthracyclines and trastuzumab. J Cardiovasc Magnet Res.2014;16(Suppl 1):P273. 57. Halliburton SS, Abbara S, Chen MY, Gentry R, Mahesh M. SCCT guidelines on radiation dose and dose-optimization strategies in cardiovascular CT. J Cardiovasc Comput Tomogr.2011;5:198-224. 58. Man SR, Man SB, Lal MJ. Role of cardiac CTA in estimating left ventricular volumes and ejection fraction. World J Radiol.2014;6(9):669-76. 59. Nacif MS, Kawel N, Lee JJ, Chen X, Yao J, Zavodni A, et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low- radiation-dose cardiac CT. Radiology.2 012;264(3):876-83. 316